James V. Donadío

6.0k total citations · 1 hit paper
75 papers, 4.0k citations indexed

About

James V. Donadío is a scholar working on Nephrology, Rheumatology and Surgery. According to data from OpenAlex, James V. Donadío has authored 75 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Nephrology, 18 papers in Rheumatology and 12 papers in Surgery. Recurrent topics in James V. Donadío's work include Renal Diseases and Glomerulopathies (38 papers), Systemic Lupus Erythematosus Research (16 papers) and Fatty Acid Research and Health (8 papers). James V. Donadío is often cited by papers focused on Renal Diseases and Glomerulopathies (38 papers), Systemic Lupus Erythematosus Research (16 papers) and Fatty Acid Research and Health (8 papers). James V. Donadío collaborates with scholars based in United States, Australia and Belgium. James V. Donadío's co-authors include Joseph P. Grande, Keith E. Holley, Erik J. Bergstralh, Eric J. Bergstralh, Kenneth P. Offord, Duane M. Ilstrup, Carl F. Anderson, Jorge A. Velosa, Richard H. Ferguson and Vicente E. Torres and has published in prestigious journals such as New England Journal of Medicine, JAMA and Annals of Internal Medicine.

In The Last Decade

James V. Donadío

69 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IgA Nephropathy

2002 507 citations James V. Donadío, Joseph P. Grande New England Journal of Medicine profile →

Peers

James V. Donadío

NEPHR

RHEUM

PRM

PFM

MB

LI Leishi China

Heather N. Reich Canada

Noémie Jourde‐Chiche France

Eri Muso Japan

Daniela Veit Barreto Brazil

Hideki Tahara Japan

Yoshihide Fujigaki Japan

Atsushi Fukatsu Japan

José Ballarín Spain

Masatomo Taniguchi Japan

LI Leishi China

James V. Donadío

2.2k ×0.9

NEPHR

1.2k ×1.5

RHEUM

464 ×0.6

PRM

382 ×0.5

PFM

643 ×1.2

MB

Citations per year, relative to James V. Donadío James V. Donadío (= 1×) peers LI Leishi

Countries citing papers authored by James V. Donadío

Since Specialization

Citations

This map shows the geographic impact of James V. Donadío's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James V. Donadío with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James V. Donadío more than expected).

Fields of papers citing papers by James V. Donadío

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James V. Donadío. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James V. Donadío. The network helps show where James V. Donadío may publish in the future.

Co-authorship network of co-authors of James V. Donadío

This figure shows the co-authorship network connecting the top 25 collaborators of James V. Donadío. A scholar is included among the top collaborators of James V. Donadío based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James V. Donadío. James V. Donadío is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Donadío, James V.. (2009). Recent Advances in IgA Nephropathy. Kidney International. 76(10). 1015–1016. 4 indexed citations

2.

Raatz, Susan K., J. Bruce Redmon, N. Wimmergren, James V. Donadío, & Douglas M. Bibus. (2009). Enhanced Absorption of n-3 Fatty Acids from Emulsified Compared with Encapsulated Fish Oil. Journal of the American Dietetic Association. 109(6). 1076–1081. 74 indexed citations

3.

Donadío, James V., Eric J. Bergstralh, Douglas M. Bibus, & Joseph P. Grande. (2006). Is Body Size a Biomarker for Optimizing Dosing of Omega-3 Polyunsaturated Fatty Acids in the Treatment of Patients with IgA Nephropathy?. Clinical Journal of the American Society of Nephrology. 1(5). 933–939. 19 indexed citations

4.

Hogg, Ronald J., Jeannette Y. Lee, Bruce A. Julian, et al.. (2006). Clinical Trial to Evaluate Omega-3 Fatty Acids and Alternate Day Prednisone in Patients with IgA Nephropathy. Clinical Journal of the American Society of Nephrology. 1(3). 467–474. 63 indexed citations

5.

Donadío, James V. & Joseph P. Grande. (2004). The role of fish oil/omega-3 fatty acids in the treatment of IgA nephropathy. Seminars in Nephrology. 24(3). 225–243. 60 indexed citations

6.

Donadío, James V.. (2002). Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrology Dialysis Transplantation. 17(7). 1197–1203. 145 indexed citations

7.

Donadío, James V., Timothy S. Larson, Erik J. Bergstralh, & Joseph P. Grande. (2001). A Randomized Trial of High-Dose Compared with Low-Dose Omega-3 Fatty Acids in Severe IgA Nephropathy. Journal of the American Society of Nephrology. 12(4). 791–799. 111 indexed citations

8.

Grande, Joseph P., Henry J. Walker, Bruce J. Holub, et al.. (2000). Suppressive effects of fish oil on mesangial cell proliferation in vitro and in vivo. Kidney International. 57(3). 1027–1040. 50 indexed citations

9.

Wyatt, Robert, Steven N. Emancipator, Valentina Kon, et al.. (1997). IgA nephropathy databank: Development of a system for management of renal biopsy acquired data. American Journal of Kidney Diseases. 29(6). 817–828. 17 indexed citations

10.

Holman, Ralph T., et al.. (1994). Essential Fatty Acid Deficiency Profiles in Idiopathic Immunoglobulin A Nephropathy. American Journal of Kidney Diseases. 23(5). 648–654. 30 indexed citations

11.

Donadío, James V., et al.. (1994). A Controlled Trial of Fish Oil in IgA Nephropathy. New England Journal of Medicine. 331(18). 1194–1199. 284 indexed citations

12.

Donadío, James V., et al.. (1994). Renal Biopsy in Clinical Practice. Mayo Clinic Proceedings. 69(10). 983–984. 1 indexed citations

13.

Donadío, James V.. (1991). Omega-3 Polyunsaturated Fatty Acids: A Potential New Treatment of Immune Renal Disease. Mayo Clinic Proceedings. 66(10). 1018–1028. 62 indexed citations

14.

Donadío, James V.. (1990). Treatment of Glomerulonephritis in the Elderly. American Journal of Kidney Diseases. 16(4). 307–311. 22 indexed citations

15.

Donadío, James V. & K. P. Offord. (1989). Reassessment of Treatment Results in Membranoproliferative Glomerulonephritis, With Emphasis on Life-Table Analysis. American Journal of Kidney Diseases. 14(6). 445–451. 45 indexed citations

16.

Velosa, Jorge A., Keith E. Holley, Kenneth P. Offord, et al.. (1989). Risk factors in idiopathic renal vasculitis and glomerulonephritis. Kidney International. 36(6). 1133–1141. 21 indexed citations

17.

Donadío, James V., Duane M. Ilstrup, Keith E. Holley, & J. Carlos Romero. (1988). Platelet-Inhibitor Treatment of Diabetic Nephropathy: A 10-Year Prospective Study. Mayo Clinic Proceedings. 63(1). 3–15. 37 indexed citations

18.

Dahlberg, Philip J., et al.. (1978). Recurrent Goodpasture’s Syndrome. Mayo Clinic Proceedings. 53(8). 533–537. 18 indexed citations

19.

Donadío, James V.. (1977). Treatment of Lupus Nephritis. The Nephron journals/Nephron journals. 19(4). 186–189. 12 indexed citations

20.

Donadío, James V., et al.. (1976). Progressive Lupus Glomerulonephritis. Mayo Clinic Proceedings. 51(8). 484–494.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact